Nanobiotix wins patent for nanoXray anticancer platform
According to the company, the patent protects composite particles that can generate free radicals or heat when excited by X-rays, and to the uses thereof in health, particularly
Insilico Medicine has entered into a strategic collaboration agreement with Takeda to deploy its AI-based Pharma.AI platform in the discovery and development of drug candidates.
This orphan medicinal product designation qualifies Tengion and its Neo-Bladder augment for European Medicines Agency (EMEA) regulatory incentives, including eligibility for protocol assistance and possible exemptions or reductions